234 related articles for article (PubMed ID: 8523594)
21. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
22. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription.
Parker SF; Felzien LK; Perkins ND; Imperiale MJ; Nabel GJ
J Virol; 1997 Mar; 71(3):2004-12. PubMed ID: 9032332
[TBL] [Abstract][Full Text] [Related]
23. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells.
Duerksen-Hughes PJ; Hermiston TW; Wold WS; Gooding LR
J Virol; 1991 Mar; 65(3):1236-44. PubMed ID: 1825340
[TBL] [Abstract][Full Text] [Related]
24. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells.
Rumpf H; Esche H; Kirch HC
Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919
[TBL] [Abstract][Full Text] [Related]
25. Differences in the interactions of oncogenic adenovirus 12 early region 1A and nononcogenic adenovirus 2 early region 1A with the cellular coactivators p300 and CBP.
Lipinski KS; Fax P; Wilker B; Hennemann H; Brockmann D; Esche H
Virology; 1999 Mar; 255(1):94-105. PubMed ID: 10049825
[TBL] [Abstract][Full Text] [Related]
26. The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300.
Wang HG; Yaciuk P; Ricciardi RP; Green M; Yokoyama K; Moran E
J Virol; 1993 Aug; 67(8):4804-13. PubMed ID: 8331729
[TBL] [Abstract][Full Text] [Related]
27. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains.
Kirshenbaum LA; Schneider MD
J Biol Chem; 1995 Apr; 270(14):7791-4. PubMed ID: 7713869
[TBL] [Abstract][Full Text] [Related]
28. Binding and modulation of p53 by p300/CBP coactivators.
Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
[TBL] [Abstract][Full Text] [Related]
29. p400 is required for E1A to promote apoptosis.
Samuelson AV; Narita M; Chan HM; Jin J; de Stanchina E; McCurrach ME; Narita M; Fuchs M; Livingston DM; Lowe SW
J Biol Chem; 2005 Jun; 280(23):21915-23. PubMed ID: 15741165
[TBL] [Abstract][Full Text] [Related]
30. Impact of E1a modifications on tumor-selective adenoviral replication and toxicity.
Sauthoff H; Pipiya T; Heitner S; Chen S; Bleck B; Reibman J; Chang W; Norman RG; Rom WN; Hay JG
Mol Ther; 2004 Oct; 10(4):749-57. PubMed ID: 15451459
[TBL] [Abstract][Full Text] [Related]
31. E1A oncogene induction of cellular susceptibility to killing by cytolytic lymphocytes through target cell sensitization to apoptotic injury.
Cook JL; Routes BA; Walker TA; Colvin KL; Routes JM
Exp Cell Res; 1999 Sep; 251(2):414-23. PubMed ID: 10471326
[TBL] [Abstract][Full Text] [Related]
32. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction.
Baluchamy S; Sankar N; Navaraj A; Moran E; Thimmapaya B
Oncogene; 2007 Feb; 26(5):781-7. PubMed ID: 16862175
[TBL] [Abstract][Full Text] [Related]
33. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis.
Howe JA; Mymryk JS; Egan C; Branton PE; Bayley ST
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5883-7. PubMed ID: 2143024
[TBL] [Abstract][Full Text] [Related]
34. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
Liu SL; Rand A; Kelm RJ; Getz MJ
Oncogene; 2000 Jul; 19(30):3352-62. PubMed ID: 10918592
[TBL] [Abstract][Full Text] [Related]
35. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47.
Qiu Y; Guo M; Huang S; Stein R
Mol Cell Biol; 2002 Jan; 22(2):412-20. PubMed ID: 11756538
[TBL] [Abstract][Full Text] [Related]
36. Functional importance of complex formation between the retinoblastoma tumor suppressor family and adenovirus E1A proteins as determined by mutational analysis of E1A conserved region 2.
Corbeil HB; Branton PE
J Virol; 1994 Oct; 68(10):6697-709. PubMed ID: 8084002
[TBL] [Abstract][Full Text] [Related]
37. Role of p300-family proteins in E1A oncogene induction of cytolytic susceptibility and tumor cell rejection.
Cook JL; Krantz CK; Routes BA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13985-90. PubMed ID: 8943047
[TBL] [Abstract][Full Text] [Related]
38. Mutations in CR1 of E1A 12S yield dominant negative suppressors of immortalization and the lytic cycle.
Malladi A; Quinlan MP
Virology; 1997 Jun; 233(1):51-62. PubMed ID: 9201216
[TBL] [Abstract][Full Text] [Related]
39. The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription.
Yavuzer U; Keenan E; Lowings P; Vachtenheim J; Currie G; Goding CR
Oncogene; 1995 Jan; 10(1):123-34. PubMed ID: 7824265
[TBL] [Abstract][Full Text] [Related]
40. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins.
Samuelson AV; Lowe SW
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12094-9. PubMed ID: 9342368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
